Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Director/PDMR Shareholding

11 Jun 2012 08:30

RNS Number : 0480F
Imaginatik PLC
11 June 2012
 

 

 

11 June 2012

Imaginatik Plc

 

("Imaginatik" or "the Company")

 

Directors' Dealings

 

The Company announced earlier today that it was proposing to raise up to £1million before expenses through a conditional placing of up to 333,333,333 new ordinary shares (the "Placing Shares") with institutional and other investors at a price of 0.3p per Placing Share (the "Placing") and that it had received irrevocable commitments to subscribe for 285,833,333 Placing Shares and expressions of interest from certain Directors of the Company to subscribe for a further 47,500,000 Placing Shares in the Placing on the same terms.

 

Following the release of its audited results for the year ended 31 March 2012, the Company is pleased to announce that Messrs Cooper, Charles and Gammon, Directors of the Company, have conditionally subscribed in the Placing for in aggregate 47,500,000 Placing Shares, as set out below, at a price of 0.3p per Placing Share.

 

In aggregate, the Company has therefore conditionally raised £1 million before expenses through a conditional placing of 333,333,333 new ordinary shares at a price of 0.3p per Placing Share.

 

The 333,333,333 new ordinary shares to be issued pursuant to the Placing will be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares, including the right to receive all dividends and other distributions declared on or after the date on which they are issued.

 

Application will be made for admission of the 333,333,333 new ordinary shares to trading on AIM ("Admission") and, subject to the requisite shareholder approval for the Placing being obtained at the General Meeting to be held on 27 June 2012, it is expected that Admission will be effective on or around 8.00 am on 28 June 2012.

 

Directors' participation in the Placing

The following directors of the Company are participating in the Placing at the Placing Price:

 

Director

Number of Placing Shares conditionally subscribed for

Amount subscribed

£

Number of shares held including Placing Shares

Percentage of enlarged issued share capital at Admission

Options held

Simon Charles

7,500,000

22,500

19,511,771

2.31

2,000,000

Matt Cooper

 25,000,000

75,000

80,139,615

9.47

19,062,500

David Gammon

 15,000,000*

45,000

27,442,564**

3.24

2,000,000

 

*includes a subscription for 8,333,333 Placing Shares for the sum of £25,000 by Sarah Gammon, the wife of David Gammon.

 

** The interest of David Gammon includes those of his wife.

 

 

The issue of the 47,500,000 Placing Shares to Directors of the Company is deemed a related party transaction under the AIM Rules for Companies. Shawn Taylor, Luis Solis, Brian Hays and Nick Goss, the independent directors, consider, having consulted with Northland Capital Partners Limited as the Company's Nominated Adviser, that the terms of the Directors' participation in the Placing are fair and reasonable insofar as shareholders of the Company are concerned.

 

Issue of options

 

Subject to Admission, Northland Capital Partners Limited has been issued 5,895,833 options to subscribe for new ordinary shares in the Company at a price of 0.5p per new ordinary share for a period of five years from the date of the General Meeting.

 

Total voting rights

 

Following the Admission of the 333,333,333 new ordinary shares to be issued pursuant to the the Placing, the Company's total issued share capital will comprise of 846,365,443 ordinary shares. The Company does not hold any ordinary shares in treasury. Therefore the total number of shares with voting rights in the Company will be 846,365,443. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

 

 

For further information please contact:

 

Imaginatik plc

Tel: 020 7917 2975

Matt Cooper, Chairman / Shawn Taylor, CFO

Northland Capital Partners Limited

Tel: 020 7796 8800

Gavin Burnell / Edward Hutton

John Howes / Alice Lane (Broking)

 

Newgate Threadneedle

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

 

About Imaginatik

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, NYSE, The Chubb Group of Insurance Companies, Boeing, Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Winchester, UK. For more information visit www.imaginatik.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFMMPTMBABBLT
Date   Source Headline
28th Jul 20154:07 pmRNSHolding(s) in Company
24th Jul 201512:50 pmRNSHolding(s) in Company
21st Jul 20155:31 pmRNSHolding(s) in Company
20th Jul 20157:00 amRNSSubscription and Director Dealings
15th Jul 20157:00 amRNSFinal Results
10th Jul 20159:23 amRNSHolding(s) in Company
1st Jul 20157:00 amRNSContract Win
29th Jun 20155:11 pmRNSHolding(s) in Company
29th Jun 20155:10 pmRNSHolding(s) in Company
29th Jun 201510:30 amRNSHolding(s) in Company
25th Jun 20157:00 amRNSHolding(s) in Company
25th Jun 20157:00 amRNSHolding(s) in Company
23rd Jun 20155:15 pmRNSHolding(s) in Company
23rd Jun 20157:00 amRNSHolding(s) in Company
22nd Jun 20157:00 amRNSMarket Update
1st Jun 20152:38 pmRNSResult of General Meeting
15th May 20157:00 amRNSPosting of Circular
14th May 20157:00 amRNSProposed Issue of Equity
13th Apr 20157:00 amRNSContract Wins
30th Mar 20157:00 amRNSContract Extension
16th Feb 20157:00 amRNSContracts win
11th Feb 20158:05 amRNSTrading Update
19th Jan 20157:00 amRNSDirector Loan
22nd Dec 201410:30 amRNSGrant of Options
17th Dec 20147:00 amRNSFive Year Contract Win
16th Dec 20147:00 amRNSContract Win
8th Dec 20147:00 amRNSInterim Results
19th Nov 20147:00 amRNSDirectorate Change
14th Nov 201411:52 amRNSBlocklisting Interim Review
24th Oct 20147:00 amRNSIssue of Equity/Director's Dealing
7th Oct 20145:04 pmRNSDirector/PDMR Shareholding
27th Aug 201410:50 amRNSHolding(s) in Company
21st Aug 20141:31 pmRNSDirector/PDMR Shareholding
18th Aug 20141:37 pmRNSHolding(s) in Company
14th Aug 20141:38 pmRNSResult of AGM
22nd Jul 20147:00 amRNSProposed Share Consolidation and Notice of AGM
1st Jul 20147:00 amRNSFinal Results
16th May 201411:40 amRNSHolding(s) in Company
15th May 20148:50 amRNSBlocklisting Interim Review
13th May 201411:47 amRNSHolding(s) in Company
12th May 20144:14 pmRNSResult of General Meeting and Exercise of Options
25th Apr 20147:00 amRNSProposed Placing and Subscription
14th Apr 20147:00 amRNSContract Wins and Trading Update
18th Mar 20147:00 amRNSContract Wins
28th Feb 201410:35 amRNSDirector's Dealing
26th Feb 201412:39 pmRNSDirector's Dealing
19th Dec 20133:38 pmRNSHolding(s) in Company
18th Dec 20137:00 amRNSExercise and Grant of Options
13th Dec 20137:00 amRNSContract Extension
3rd Dec 20137:00 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.